Navigation Links
NutraCea Provides Update on Domestic Operations
Date:1/28/2008

PHOENIX, Jan. 28 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB), nutrient research and technology, today provided an update on its domestic operations.

The Company stated that its Stage Two facility located in Dillon, Montana has been running at full capacity since the middle of the fourth quarter and is continuing to run 24/7, except when it is disassembled for cleaning. Further, the facility is fully committed to run at full capacity through the end of 2008.

Concerning the pending Phoenix Stage Two facility, Leo Gingras, Chief Operating Officer of NutraCea, commented, "We are very pleased with the strong demand that we have been receiving for our Stage Two products. Based on this, we have decided to enlarge the size of our new Phoenix facility from 50,000 square feet to between 100,000-125,000 square feet. As mentioned previously, this new facility will also include processing and packaging systems that will be utilized for unique customer requirements, including those in the baby cereal business."

"We are in the process of purchasing an existing building, and all of the equipment is currently being constructed. We expect to begin installing this equipment during the first half of this year and to have the facility operational by the end of the third quarter," said Gingras.

Construction on NutraCea's Stage One Southern Louisiana facility at Lake Charles is anticipated to be completed by the end of the first quarter. This facility will have the capacity to provide up to 30,000 tons of stabilized rice bran annually. To view photographs of the progress at this site visit the Company's web site at: http://www.nutracea.com/facilities

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufactures as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future completion of a new facilities, the continued operation of existing facilities, and the market demand from new accounts for the materials to be produced at the new and existing facilities, all of which statements are subject to market risks, and the possibility that NutraCea will not be able to complete the facilities on a timely basis, to continue the operations at existing facilities at full production levels, or to obtain sufficient customer demand to utilize expected production from the new and existing facilities. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward- looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.

Company Contact:

Margie Adelman

Senior V.P. NutraCea

602-522-3000

916-220-3500 cell

madelman@nutracea.com

Investor Relations Contact:

Marilynn Meek

Financial Relations Board

212-827-3773

mmeek@frbir.com


'/>"/>
SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
2. NutraCea Announces Conference Call to Report Second Quarter Financial Results
3. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
4. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
5. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
6. NJHA: State Report Provides Thorough Examination of Hospital Fiscal Woes
7. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
8. New Blog Provides Forum for Discussions on Supplement Safety
9. American HealthChoice CEO Dr. J.W. Stucki Provides Company Update
10. New pathway provides more clues about BRCA1 role in breast cancer
11. Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: